Publications
Résultats 151 à 160 sur 560 Publications
Titre | Auteurs | Année | Revue |
---|---|---|---|
Reentrant liquid condensate phase of proteins is stabilized by hydrophobic and non-ionic interactions | Krainer G, Welsh TJ, Joseph JA, Espinosa JR, Wittmann S, de Csilléry E, Sridhar A, Toprakcioglu Z, Gudiškytė G, Czekalska MA, Arter WE, Guillén-Boixet J, Franzmann TM, Qamar S, George-Hyslop PS*, Hyman AA, Collepardo-Guevara R, Alberti S, Knowles TPJ. | 2021 | Nature Communications |
Biomarker modeling of Alzheimer’s disease using PET-based Braak staging | Therriault, J.**, Pascoal, T. A**., Lussier, F. Z., Tissot, C., Chamoun, M., Bezgin, G., Servaes S., Benedet A.L., Ashton N.J., Karikari T.K., Lantero-Rodriguez J., Kunach P., Wang Y-T., Fernandez-Arias J., Massarweh G., Vitali P., Soucy J-P., Saha-Chaudhuri P., Blennow, K., Zetterberg H., Gauthie S.*, & Rosa-Neto, P.* | 2022 | Nature Aging |
The degree of frailty as a translational measure of health in aging | Howlett SE, Rutenberg AD, Rockwood K* | 2021 | Nature Aging |
A two-step workflow based on plasma p-tau217 to screen for amyloid β positivity with further confirmatory testing only in uncertain cases | Brum, W. S., Cullen, N. C., Janelidze, S., Ashton, N. J., Zimmer, E. R., Therriault, J.**, Benedet, A. L., Rahmouni, N.**, Tissot, C.**, Stevenson, J., Servaes, S., Triana-Baltzer, G., Kolb, H. C., Palmqvist, S., Stomrud, E., Rosa-Neto, P.*, Blennow, K., & Hansson, O | 2023 | Nature aging |
SMPD1 mutations, activity, and alpha-synuclein accumulation in Parkinson’s disease. | Alcalay, R.N., Mallett, V., Vanderperre, B., Tavassoly, O., Dauvilliers, Y., Wu, R.Y.J., Ruskey, J.A., Leblond, C.S., Ambalavanan, A., Laurent, S.B., Spiegelman, D., Dionne-Laporte, A., Liong, C., Levy, O.A., Fahn, S., Waters, C., Kuo, S.H., Chung, W.K., Ford, B., Marder, K.S., Kang, U.J., Hassin-Baer, S., Greenbaum, L., Trempe, J.F., Wolf, P., Oliva, P., Zhang, X.K., Clark, L.N., Langlois, M., Dion, P.A., Fon, E.A.**, Dupre, N.**, Rouleau, G.A.**, Gan-Or, Z**. | 2019 | Movement Disorders. |
Type 2 Diabetes as a Determinant of Parkinson’s Disease Risk and Progression | Chohan H, Senkevich K, Patel RK, Bestwick JP, Jacobs BM, Bandres Ciga S, Gan-Or Z*, Noyce AJ. | 2021 | Movement Disorders |
Analysis of Heterozygous PRKN Variants and Copy-Number Variations in Parkinson’s Disease | Yu E, Rudakou U, Krohn L, Mufti K, Ruskey JA, Asayesh F, Estiar MA, Spiegelman D, Surface M, Fahn S, Waters CH, Greenbaum L, Espay AJ, Dauvilliers Y, Dupré N, Rouleau GA*, Hassin-Baer S, Fon EA*, Alcalay RN, Gan-Or Z* | 2020 | Movement Disorders |
C9orf72 and ATXN2 repeat expansions coexist in a family with ataxia, dementia, and parkinsonism. | Zhang, M.**, Xi, Z., Misquitta, K., Sato, C., Moreno, D., Liang, Y., Slow, E., Rogaeva, E., & Tartaglia, M. C. | 2017 | Movement Disorders |
Full sequencing and haplotype analysis of MAPT in Parkinson’s disease and rapid eye movement sleep behavior disorder | Li, J., Ruskey, J.A., Arnulf, I., Dauvilliers, Y., Hu, M.T.M., Hogl, B., Leblond, C.S., Zhou, S., Ambalavanan, A., Ross, J.P., Bourassa, C.V., Spiegelman, D., Laurent, S.B., Stefani, A., Charley Monaca, C., Cochen De Cock, V., Boivin, M., Ferini-Strambi, L., Plazzi, G., Antelmi, E., Young, P., Heidbreder, A., Labbe, C., Ferman, T.J., Dion, P.A., Fan, D., Desautels, A., Gagnon, J.F., Dupre, N., Fon, E.A., Montplaisir, J.Y., Boeve, B.F., Postuma, R.B., Rouleau, G.A., Ross, O.A., & Gan-Or, Z. | 2018 | Movement Disorders |
Profiling novel metabolic biomarkers for Parkinson’s disease using in‐depth metabolomic analysis | Han, W., Sapkota, S., Camicioli, R., Dixon, R. A., & Li, L. | 2017 | Movement Disorders |
Résultats 151 à 160 sur 560 Publications